WallStSmart

Amrize Ltd (AMRZ)vsEagle Materials Inc (EXP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Amrize Ltd generates 416% more annual revenue ($11.91B vs $2.31B). EXP leads profitability with a 18.4% profit margin vs 9.7%. AMRZ appears more attractively valued with a PEG of 1.49. EXP earns a higher WallStSmart Score of 55/100 (C).

AMRZ

Hold

49

out of 100

Grade: D+

Growth: 4.0Profit: 5.0Value: 5.7Quality: 5.0
Piotroski: 2/9Altman Z: 1.61

EXP

Buy

55

out of 100

Grade: C

Growth: 3.3Profit: 8.5Value: 4.7Quality: 6.5
Piotroski: 3/9Altman Z: 2.24
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AMRZ.

EXPSignificantly Overvalued (-57.7%)

Margin of Safety

-57.7%

Fair Value

$145.64

Current Price

$212.72

$67.08 premium

UndervaluedFair: $145.64Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMRZ1 strengths · Avg: 8.0/10
Price/BookValuation
2.3x8/10

Reasonable price relative to book value

EXP2 strengths · Avg: 8.5/10
Return on EquityProfitability
28.7%9/10

Every $100 of equity generates 29 in profit

P/E RatioValuation
16.8x8/10

Attractively priced relative to earnings

Areas to Watch

AMRZ4 concerns · Avg: 4.0/10
P/E RatioValuation
26.5x4/10

Moderate valuation

Revenue GrowthGrowth
4.7%4/10

4.7% revenue growth

EPS GrowthGrowth
3.6%4/10

3.6% earnings growth

Altman Z-ScoreHealth
1.614/10

Distress zone — elevated risk

EXP4 concerns · Avg: 3.5/10
PEG RatioValuation
2.094/10

Expensive relative to growth rate

Revenue GrowthGrowth
1.9%4/10

1.9% revenue growth

Debt/EquityHealth
1.223/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : AMRZ

The strongest argument for AMRZ centers on Price/Book. PEG of 1.49 suggests the stock is reasonably priced for its growth.

Bull Case : EXP

The strongest argument for EXP centers on Return on Equity, P/E Ratio. Profitability is solid with margins at 18.4% and operating margin at 17.4%.

Bear Case : AMRZ

The primary concerns for AMRZ are P/E Ratio, Revenue Growth, EPS Growth.

Bear Case : EXP

The primary concerns for EXP are PEG Ratio, Revenue Growth, Debt/Equity.

Key Dynamics to Monitor

AMRZ is growing revenue faster at 4.7% — sustainability is the question.

EXP generates stronger free cash flow (-20M), providing more financial flexibility.

Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

EXP scores higher overall (55/100 vs 49/100), backed by strong 18.4% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amrize Ltd

BASIC MATERIALS · BUILDING MATERIALS · USA

Amrize Ltd (AMRZ) is a pioneering technology company specializing in the digital health and wellness sector, committed to revolutionizing healthcare delivery through cutting-edge technologies and data-centric solutions. With a robust emphasis on enhancing patient outcomes and accessibility, Amrize allocates substantial resources to research and development, positioning itself to meet the escalating demand for scalable health innovations. Its strategic initiatives, coupled with a diverse portfolio of products, underscore Amrize's potential as a crucial player in the ongoing transformation of healthcare, offering an appealing investment opportunity for institutional investors in a dynamic market landscape.

Visit Website →

Eagle Materials Inc

BASIC MATERIALS · BUILDING MATERIALS · USA

Eagle Materials Inc., produces and supplies heavy construction materials, lightweight construction materials and materials used for the extraction of oil and natural gas in the United States. The company is headquartered in Dallas, Texas.

Want to dig deeper into these stocks?